@article{7af7306834f84199881034b64bc7d146,
title = "Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study",
keywords = "Child, Female, Gene Rearrangement, Humans, Infant, Male, Neoplasm Proteins/genetics, Nuclear Proteins/genetics, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/genetics, Prognosis, Survival Rate",
author = "Boer, \{Judith M\} and Valsecchi, \{Maria Grazia\} and Hormann, \{Femke M\} and {\v Z}eljko Anti{\'c} and Marketa Zaliova and Claire Schwab and Giovanni Cazzaniga and Chlo{\'e} Arfeuille and H{\'e}l{\`e}ne Cav{\'e} and Andishe Attarbaschi and Sabine Strehl and Gabriele Escherich and Toshihiko Imamura and Kentaro Ohki and Gr{\"u}ber, \{Tanja A\} and Rosemary Sutton and Agata Pastorczak and Tim Lammens and Fr{\'e}d{\'e}ric Lambert and Li, \{Chi Kong\} and \{Carrillo de Santa Pau\}, Enrique and Steve Hoffmann and Anja M{\"o}ricke and Harrison, \{Christine J\} and \{Den Boer\}, \{Monique L\} and \{De Lorenzo\}, Paola and Stam, \{Ronald W\} and Bergmann, \{Anke K\} and Rob Pieters",
note = "Funding Information: This study was conducted on behalf of the Ponte di Legno Childhood ALL Working Group. The authors gratefully acknowledge samples and data provided by the Blood Cancer UK Childhood Leukaemia Cell Bank, the Center for Biological Resources (CRB-cancer; BB-0033-00076) of the Robert Debr{\'e} Hospital, the Sydney Children{\textquoteright}s Tumour Bank Network, the Vienna BioCenter Core Facilities (VBCF; www.viennabiocenter.org/ facilities) Next-Generation Sequencing Unit, and the Blueprint Consortium. The authors would like to thank Karin Nebral and Oskar A. Haas for providing genetic data, Georg Mann for clinical data and patient samples, Dagmar Schinnerl for bioinformatics analysis of RNA-sequencing data (Berlin-Frankfurt-M{\"u}nster – Austria study group), Tomasz Szczepanski and Wojciech Mlynarski (Polish Pediatric Leukaemia and Lymphoma Study Group), Martin Schrappe and Martin Zimmermann (Berlin-Frankfurt-M{\"u}nster - Germany/ Switzerland study group), Alex Hoogkamer and Valerie de Haas (Dutch Childhood Oncology Group), Udo zur Stadt (Cooperative Study Group for Childhood ALL), Benoit Brethon (Soci{\'e}t{\'e} Fran{\c c}aise de la lutte contre les Cancers et les leuc{\'e}mies de l{\textquoteright}Enfant et de l{\textquoteright}Adolescent), and Rishi Kotecha (Australian \& New Zealand Childrens Hematology/ Oncology Group). This project was supported by grants from the Oncode Institute (M.L. D.B.), Stichting Kinderoncologisch Centrum Rotterdam (M.L.D.B.), KiKa Foundation (KiKa-264; J.M.B.), vzw Kinderkankerfonds (T.L.), DFG grants (BE6555/1-1 (AKB), BE6555/2-1 (A. K.B., S.H.)), Anniversary Fund of the Oesterreichische Nationalbank (OeNB 18281; S.S.), Polpharma Scientific Foundation, grant No. 4/19/IX/1, the ERA-NET TRANSCAN EJC granted by Fondation ARC (www.fondation-arc.org) (A.P.), and European Union{\textquoteright}s Seventh Framework Program (FP7/2007–2013, 282510 (BLUEPRINT)).",
year = "2021",
month = oct,
doi = "10.1038/s41375-021-01333-y",
language = "English",
volume = "35",
pages = "2978--2982",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Springer Nature",
number = "10",
}